Lv3
380 积分 2021-06-01 加入
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
2天前
已完结
A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumors
2天前
已完结
Fluorinated lipid nanoparticles enable in vivo CAR-macrophage therapy in solid tumor and enhance anti PD-L1 immunotherapy
2天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
10天前
已完结
Effective use of BCMA-targeting bispecific T cell-engaging antibody in treatment-refractory LRP4+ myasthenia gravis
17天前
已完结
In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial
18天前
已完结
The Care and Cure of the Leukemias in 2026
25天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
IPNA consensus definitions for clinical trial outcomes in steroid-resistant nephrotic syndrome
2个月前
已完结
皖公网安备34019202002308
